Zealand Pharma reports higher costs in 2021
While Zealand Pharma’s costs went up last year, the company expects spending in 2022 to reach around the same level as the two financial periods preceding 2021.
by marketwire, translated by daniel pedersen
On Thursday, Zealand Pharma publicized its annual report for 2021, showcasing lower sales and greater costs compared to the preceding year.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Zealand Pharma enters USD 200m financing agreement
For subscribers
Zealand Pharma finishes phase III enrollment
For subscribers
.jpg&w=384&q=75)
